Seeing Is Believing
Currently out of the existing stock ratings of Robert Wasserman, 84 are a BUY (87.5%), 12 are a HOLD (12.5%).
Analyst Robert Wasserman, currently employed at BENCHMARK, carries an average stock price target met ratio of 37.67% that have a potential upside of 52.51% achieved within 111 days.
Robert Wasserman’s has documented 172 price targets and ratings displayed on 16 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on HALO, Halozyme Therapeutics at 24-Sep-2025.
Analyst best performing recommendations are on EBS (EMERGENT BIOSOLUTIONS).
The best stock recommendation documented was for IPA (IMMUNOPRECISE ANTIBODIES LTD) at 4/1/2025. The price target of $3 was fulfilled within 143 days with a profit of $2.62 (689.47%) receiving and performance score of 48.21.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$7
$5.04 (257.14%)
3 years 1 months 20 days ago
(18-Aug-2022)
0/1 (0%)
$2.29 (48.62%)
Which stock is Robert Wasserman is most bullish on?
Which stock is Robert Wasserman is most reserved on?
What Year was the first public recommendation made by Robert Wasserman?